|
"lung fdt"的相關文件
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
| 中國醫藥大學 |
2005 |
Small nonphosphorylated Grb2-SH2 domain antagonists evaluated by surface resonance plasmon technology
|
Lung, FDT; Chang, CW; Chong, MC; Liou, CC; Li, P; Peach, ML; Nicklaus, MC; Lou, BS; Roller, PP |
| 中國醫藥大學 |
2004 |
Surface plasmon resonance detection of interactions between peptide fragments of N-telopeptide and its monoclonal antibodies
|
Lung, FDT; Chen, CH; Liou, CC; Chen, HY |
| 中國醫藥大學 |
2003 |
Monitoring bone loss using ELISA and surface plasmon resonance (SPR) technology
|
Lung, FDT; Chen, HY; Lin, HT |
| 中國醫藥大學 |
2003 |
Grb2 SH2 domain-binding peptide analogs as potential anticancer agents
|
Lung, FDT; Tsai, JY |
| 中國醫藥大學 |
2002 |
Novel peptide inhibitors for Grb2 SH2 domain and their detection by surface plasmon resonance
|
Lung, FDT; Tsai, JY; Wei, SY; Cheng, JW; Chen, C; Li, P; Roller, PP |
| 中國醫藥大學 |
2002 |
Binding potency of peptide fragments of type 1 collagen cross-linked N-telopeptide measured by an enzyme-linked immunosorbant assay
|
Lung, FDT; Chen, CH; Chen, HY; Liou, CC; Liou, YM |
| 中國醫藥大學 |
2000 |
Stability and peptide binding specificity of Btk SH2 domain: Molecular basis for X-linked agammaglobulinemia
|
Tzeng, SR; Pai, MT; Lung, FDT; Wu, CW; Roller, PP; Lei, BF; Wei, CJ; Tu, SC; Chen, SH; Soong, WJ; Cheng, JW |
| 中國醫藥大學 |
1999 |
Solution structure and dynamics of G1TE, a nonphosphorylated cyclic peptide inhibitor for the Grb2 SH2 domain
|
Lou, YC; Lung, FDT; Pai, MT; Tzeng, SR; Wei, SY; Roller, PP; Cheng, JW |
顯示項目 1-8 / 8 (共1頁)
1
每頁顯示[10|25|50]項目
|
